Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3326)
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
7,500
Price
$76.76
Total Value
$575.70K
Shares Held After
377,820
% of Holdings
1.9%
Ensysce Biosciences, Inc. (ENSC)
GOWER BOB G — Director
Shares
400,000
Price
$0.49
Total Value
$198.00K
Shares Held After
916,740
% of Holdings
43.6%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Veness Adam M — SVP, General Counsel and Sec.
Shares
616
Price
$111.18
Total Value
$68.49K
Shares Held After
0
% of Holdings
100.0%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Veness Adam M — SVP, General Counsel and Sec.
Shares
3,217
Price
$110.61
Total Value
$355.83K
Shares Held After
616
% of Holdings
83.9%
Immunome Inc. (IMNM)
Barchas Isaac — Director
Shares
15,248
Price
$26.06
Total Value
$397.36K
Shares Held After
72,416
% of Holdings
17.4%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Moran Sean F. — Chief Financial Officer
Shares
12,000
Price
$10.08
Total Value
$120.97K
Shares Held After
84,694
% of Holdings
12.4%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Cohen Yuval — Director
Shares
17,000
Price
$10.08
Total Value
$171.40K
Shares Held After
157,316
% of Holdings
9.8%
Spyre Therapeutics, Inc. (SYRE)
Albers Jeffrey W. — Director
Shares
10,000
Price
$104.68
Total Value
$1.05M
Shares Held After
9,360
% of Holdings
51.7%
Spyre Therapeutics, Inc. (SYRE)
Albers Jeffrey W. — Director
Shares
8,000
Price
$104.38
Total Value
$835.04K
Shares Held After
19,360
% of Holdings
29.2%
Spyre Therapeutics, Inc. (SYRE)
Albers Jeffrey W. — Director
Shares
5,000
Price
$104.47
Total Value
$522.35K
Shares Held After
0
% of Holdings
100.0%
MANNKIND CORP (MNKD)
Binder Steven B. — Director
Shares
39,051
Price
$4.06
Total Value
$158.55K
Shares Held After
785,867
% of Holdings
4.7%
Entrada Therapeutics, Inc. (TRDA)
5AM Ventures V, L.P. — 10% Owner
Shares
52,317
Price
$6.85
Total Value
$358.37K
Shares Held After
2,783,781
% of Holdings
1.8%
Entrada Therapeutics, Inc. (TRDA)
PARMAR KUSH — Director
Shares
52,317
Price
$6.85
Total Value
$358.37K
Shares Held After
2,783,781
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$540.32
Total Value
$64.84K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
632
Price
$539.14
Total Value
$340.74K
Shares Held After
324,563
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
625
Price
$538.54
Total Value
$336.59K
Shares Held After
325,195
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$536.99
Total Value
$193.32K
Shares Held After
325,820
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$535.31
Total Value
$85.65K
Shares Held After
326,180
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$534.27
Total Value
$106.85K
Shares Held After
326,340
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$533.37
Total Value
$85.34K
Shares Held After
326,540
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
183
Price
$532.01
Total Value
$97.36K
Shares Held After
326,700
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,781
Price
$531.30
Total Value
$1.48M
Shares Held After
326,883
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,450
Price
$530.32
Total Value
$768.96K
Shares Held After
329,664
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
709
Price
$529.14
Total Value
$375.16K
Shares Held After
331,114
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$527.72
Total Value
$126.65K
Shares Held After
331,823
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
411
Price
$526.82
Total Value
$216.52K
Shares Held After
332,063
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,112
Price
$526.15
Total Value
$585.08K
Shares Held After
332,474
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
357
Price
$525.29
Total Value
$187.53K
Shares Held After
333,586
% of Holdings
0.1%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
3,500
Price
$8.62
Total Value
$30.17K
Shares Held After
83,500
% of Holdings
4.2%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
34,000
Price
$8.62
Total Value
$293.05K
Shares Held After
790,000
% of Holdings
4.3%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
21,909
Price
$108.72
Total Value
$2.38M
Shares Held After
65,292
% of Holdings
25.1%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
104,091
Price
$107.96
Total Value
$11.24M
Shares Held After
87,102
% of Holdings
54.4%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
800
Price
$110.76
Total Value
$88.61K
Shares Held After
191,292
% of Holdings
0.4%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
2,536
Price
$110.02
Total Value
$279.01K
Shares Held After
192,092
% of Holdings
1.3%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
2,373
Price
$109.10
Total Value
$258.89K
Shares Held After
194,628
% of Holdings
1.2%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
23,907
Price
$108.05
Total Value
$2.58M
Shares Held After
197,001
% of Holdings
10.8%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
10,384
Price
$107.49
Total Value
$1.12M
Shares Held After
220,908
% of Holdings
4.5%
Korro Bio, Inc. (KRRO)
Lynx1 Capital Management LP — 10% Owner
Shares
5,222
Price
$11.40
Total Value
$59.53K
Shares Held After
1,543,518
% of Holdings
0.3%
Immunome Inc. (IMNM)
Barchas Isaac — Director
Shares
20,840
Price
$26.06
Total Value
$543.09K
Shares Held After
87,664
% of Holdings
19.2%
Entrada Therapeutics, Inc. (TRDA)
5AM Ventures V, L.P. — 10% Owner
Shares
10,494
Price
$7.00
Total Value
$73.46K
Shares Held After
2,836,098
% of Holdings
0.4%
Entrada Therapeutics, Inc. (TRDA)
PARMAR KUSH — Director
Shares
10,494
Price
$7.00
Total Value
$73.46K
Shares Held After
2,836,098
% of Holdings
0.4%
Protagenic Therapeutics, Inc.\new (PTIX)
ARMEN GARO H — Director
Shares
685
Price
$0.22
Total Value
$150.70
Shares Held After
31,979
% of Holdings
2.1%
Axsome Therapeutics, Inc. (AXSM)
TABUTEAU HERRIOT — Director
Shares
4,660
Price
$213.95
Total Value
$997.01K
Shares Held After
7,229
% of Holdings
39.2%
ACADIA PHARMACEUTICALS INC (ACAD)
Schneyer Mark C. — EVP, CHIEF FINANCIAL OFFICER
Shares
9,292
Price
$29.34
Total Value
$272.60K
Shares Held After
67,828
% of Holdings
12.0%
ACADIA PHARMACEUTICALS INC (ACAD)
Schneyer Mark C. — EVP, CHIEF FINANCIAL OFFICER
Shares
5,000
Price
$29.00
Total Value
$145.00K
Shares Held After
77,120
% of Holdings
6.1%
Fortrea Holdings Inc. (FTRE)
Thakral Anshul — Director
Shares
55,975
Price
$18.06
Total Value
$1.01M
Shares Held After
204,940
% of Holdings
21.5%
Fortrea Holdings Inc. (FTRE)
Thakral Anshul — Director
Shares
55,882
Price
$18.17
Total Value
$1.02M
Shares Held After
260,915
% of Holdings
17.6%
PRECIGEN, INC. (PGEN)
Shah Rutul R — Chief Operating Officer
Shares
32,739
Price
$6.86
Total Value
$224.59K
Shares Held After
465,012
% of Holdings
6.6%
Disc Medicine, Inc. (IRON)
Khara Rahul — Chief Legal Officer
Shares
5,000
Price
$80.00
Total Value
$400.00K
Shares Held After
52,324
% of Holdings
8.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
420
Price
$532.39
Total Value
$223.61K
Shares Held After
324,443
% of Holdings
0.1%
Showing 351–400 of 3326 transactions (page 8 of 67)